Tuberculosis

  • A MDR-TB survivor from North Jakarta, Indonesia with a community health cadre volunteer. Photo credit: USAID

    USAID announces the TB Local Organizations Network Annual Program Statement as a key component of the Global Accelerator to End Tuberculosis.

    Learn More
  • A group of Indian women raise their hands in solidarity against TB. Caption reads: USAID Global Accelerator to End TB

    To accelerate action on TB, USAID has announced an innovative model, “The Global Accelerator to End Tuberculosis.”

    Learn More
  • USAID trained Jennifer and other health volunteers to teach their community about TB and to serve as treatment partners for people with the disease. Photo credit: Kdador/PBSP. Courtesy USAID Philippines

    The U.S. Government Departments and Agencies charged with implementing the National Action Plan for Combating Multidrug-Resistant Tuberculosis continue to make notable progress towards achieving the Plan's established milestones.

    Learn More
  • Administrator Green speaks with TB survivors during his trip to Hyderabad, India. November 2017.

    Administrator Green spoke about ending the tuberculosis epidemic in India during his November 2017 trip.

    Learn More
  • Combating Antibiotic-Resistant Bacteria

    Through technical assistance led by the U.S. Agency for International Development (USAID) and our innovative partnership with Johnson & Johnson, we are scaling up multidrug-resistant TB treatment programs in over 25 countries.

    Learn More
  • A doctor checks the abdomen of a patient.

    As the lead U.S. Government agency for global TB care, USAID works with partners to reach every person with TB, cure those in need of treatment and prevent new TB infections.

    Learn More

 

At USAID, we focus our investments on strengthening national TB strategies and programs through bilateral projects in priority countries with high rates of TB, drug-resistant TB and HIV-associated TB.

Graphic of a man coughing - 10.0 million new cases of TB
Graphic of a pair of lungs. 1.6 million deaths from TB
Graphic of a microscope. 588,000 new drug-resistant TB cases
Graphic of two pills. 140,000 drug-resistant TB patients started care

The U.S. Agency for International Development (USAID) supports high-quality screening, diagnosis and treatment services for millions of people affected by TB and multidrug-resistant tuberculosis (MDR-TB). In Fiscal Year 2017, with investments of $244 million focused primarily in 22 countries with bilateral TB funds, the U.S. Government achieved the following results in collaboration with each country's National TB Program:

22

Countries with bilateral programs

54

Countries received technical assistance

4,000,000

TB cases detected

3

Percent increase in case notifications

88

 Percent treatment success rate

83,000

Individuals with DR-TB started on appropriate treatment

27,600,000

Xpert cartridges procured under concessional pricing (cumulative)

62

Countries utilized the Bedaquiline Donation Program (cumulative)

36,000

Health workers trained

19

Countries completed drug-resistance surveys (cumulative)

20

Countries completed/completing TB prevalence surveys (cumulative)

5

Research studies focused on new treatment regimens supported

USAID's investments contributed to an estimated 54 million lives saved between 2000-2017, including people co-infected with HIV/AIDS.

Learn more about our work in 2017.

 

What We Do

USAID works with partner governments to:

  • Prevent TB transmission and renew efforts to find the missing TB cases
  • Strengthen the capacity of national TB programs
  • Build country capacity to use existing resources and to turn evidence into policy
  • Expand the development of new TB diagnostics, drugs and vaccines

Last updated: February 13, 2019

Share This Page